HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,473-2,484 of 4,505
Drug study icon
CompletedNCT02151656

F17464 in Acute Schizophrenia study

What is this study about?

Researchers compared F17464 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Nîmes
SchizophreniaMedication studyAges 18–64
Countries
France, Hungary, Latvia, + 2 others
Sponsor
Pierre Fabre Medicament
Other study type icon
CompletedNCT02166918

Factors Influencing Social Functioning of People With Schizophrenia

Official study title

Multicenter Study on Factors Influencing Real-life Social Functioning of People With a Diagnosis of Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Naples
SchizophreniaObservational studyAges 18–65
Countries
Italy
Sponsor
University of Campania Luigi Vanvitelli
Behavioral study icon
CompletedNCT01312649

Feeling of Being in Control of One's Own Action

Official study title

Feeling of Being in Control of One's Own Action: Which Mechanisms in Healthy Volunteers and in Mental Diseases

This study has finished and is no longer accepting participants.

In Strasbourg
Schizophrenia, BipolarityBehavioural studyAges 18–55
Countries
France
Sponsor
University Hospital, Strasbourg, France
Drug study icon
CompletedNCT01779700

Fingolimod in Schizophrenia Patients

What is this study about?

This study evaluated the safety and effectiveness of Fingolimod for people with schizophrenia.

This study has finished and is no longer accepting participants.

In Indianapolis
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Indiana University
Drug study icon
CompletedNCT02892422

Flexible-dose, Long-term Safety Study of Lu AF35700 in adults with Schizophrenia

What is this study about?

Researchers studied Lu AF35700, tracking side effects to assess long-term safety and tolerability in adults with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Bellflower
SchizophreniaMedication studyAges 18+
Countries
United States, Canada, Bulgaria, + 10 others
Sponsor
H. Lundbeck A/S

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.